Phase 1B trial of anti-notch 2/3 antibody OMP-59R5 in combination with etoposide and cisplatin (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC): The pinnacle study Meeting Abstract
| Authors: | Pietanza, M. C.; Spira, A.; Jotte, R.; Gadgeel, S.; Mita, A.; Liu, S.; Gluck, W. L.; Kalemkerian, G. P.; Chiang, A.; Hart, L.; Kapoun, A.; Xu, L.; Hill, D.; Zhou, L.; Dupont, J.; Spigel, D. R. |
| Abstract Title: | Phase 1B trial of anti-notch 2/3 antibody OMP-59R5 in combination with etoposide and cisplatin (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC): The pinnacle study |
| Meeting Title: | 39th ESMO Congress (ESMO 2014) |
| Journal Title: | Annals of Oncology |
| Volume: | 25 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2014 Sep 26-30 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2014-09-01 |
| Start Page: | iv514 |
| End Page: | iv515 |
| Language: | English |
| ACCESSION: | WOS:000346901000426 |
| DOI: | 10.1093/annonc/mdu355.11 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1473P -- Source: Wos |
